Author:
Zhao Mingming,Su Min,Lin Xia,Luo Yanfei,He Haibing,Cai Cuifang,Tang Xing
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference31 articles.
1. Clarke SJ, Rivory LP. Clinical pharmacokinetics of docetaxel. Clin Pharmacol Ther. 1999;36:99–114.
2. Verweij J, Clavelf M, Chevalier B. Paclitaxel (Taxol™) and docetaxel (Taxotere™): not simply two of a kind. AnnOncol. 1994;5:495–505.
3. Drori S, Eytan GD, Assaraf YG. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alteration in membrane fluidity leading to increased membrane permeability. Eur J Biochem. 1995;228:1020–9.
4. Ceruti M, Tagini V, Recalenda V, Arpicco S, Cattel L, Airoldi M, et al. Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions. Il Farmaco. 1999;54:733–9.
5. Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release. 2003;91:417–29.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献